Perception, prevalence, and pattern of complementary and alternative medicine use among adults living with sickle cell disease in Lagos, Nigeria.
Afrischolar Discovery · 21.02.2024
DOI: 10.60787/wapcp-32-2-243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Afrischolar Discovery, erschienen am 21.02.2024. Verfasst von Oluwole und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Nigeria has the largest population of people with Sickle Cell Disease (SCD). About 2.3% of the population suffer from the disease while about 25% are healthy carriers of the sickle cell gene. Painful crises are usually the common cause of frequent hospitalization among people living with SCD, hence, majority of these patients are now turning to the use of Complementary and Alternative Medicines (CAM).
Objectives
This study determined the perception, prevalence and pattern of CAM use among adults living with SCD in Lagos, Nigeria.
Methods
A cross-sectional survey was conducted among 301 SCD. Adults in Lagos State, from April to November 2019. Respondents were interviewed using a semi-structured pretested questionnaire. Descriptive, bivariate and multivariate analyses were conducted using SPSS Version 22. Level of significance was set at p
Schlagwörter
Zitieren
APA
Oluwole, O., E., Akanji, O., I., Busari, & A., A. (2024). Perception, prevalence, and pattern of complementary and alternative medicine use among adults living with sickle cell disease in Lagos, Nigeria. Afrischolar Discovery. https://doi.org/10.60787/wapcp-32-2-243
Vancouver
Oluwole, O. E, Akanji, O. I, Busari, A. A. Perception, prevalence, and pattern of complementary and alternative medicine use among adults living with sickle cell disease in Lagos, Nigeria. Afrischolar Discovery. 2024. doi:10.60787/wapcp-32-2-243
BibTeX
@article{Oluwole2024,
author = {Oluwole and O., Esther and Akanji and O., Ibukunoluwa and Busari and A., Abdulwasiu.},
title = {Perception, prevalence, and pattern of complementary and alternative medicine use among adults living with sickle cell disease in Lagos, Nigeria},
journal = {Afrischolar Discovery},
year = {2024},
doi = {10.60787/wapcp-32-2-243}
}
EUVIMED